Skip to main content

Table 1 Baseline characteristics of patients with suspected cardiac dyspneaa

From: Management of suspected acute heart failure dyspnea in the emergency department: results from the French prospective multicenter DeFSSICA survey

 

HF (n = 537)

Not HF (n = 158)

P

Age, y

83 (77–88)

79 (67–88)

.00069

Men

235 (44)

76 (48)

.38

Comorbidities

 Hypertension

378 (71)

90 (57)

.0015

 Chronic heart failure

288 (54)

59 (37)

.00035

 Atrial fibrillation

239 (45)

54 (34)

.023

 Coronary heart disease

161 (30)

37 (23)

.12

 Diabetes mellitus

152 (28)

37 (23)

.18

 Chronic renal failure

120 (28)

30 (19)

.41

 Chronic respiratory failure

92 (17)

32 (20)

.43

 Known valvular disease

99 (19)

22 (16)

.22

Prior medications

 Furosemide

315 (59)

67 (43)

.00059

 ACEI/ARB

242 (45)

52 (36)

.011

 β-blocker

231 (43)

44 (28)

.0010

 Anticoagulant

236 (44)

48 (31)

.0038

 Aspirin

163 (31)

40 (26)

.28

 Other antiplatelet

61 (11)

16 (10)

.80

 Oral antidiabetic

71 (13)

19 (12)

.83

 Insulin

71 (13)

10 (6.3)

.028

 Amiodarone

58 (11)

19 (12)

.74

 Aldosterone antagonist

39 (7.3)

11 (6.9)

.94

 Digoxin

41 (7.6)

8 (5.1)

.36

 Thiazidine

34 (6.3)

12 (7.6)

.68

 None

29 (5.4)

19 (12)

.0060

 Unknown

13 (2.4)

7 (4.4)

.28

Pacemaker

 Single

18 (3.3)

4 (2.5)

.81

 Dual

39 (7.3)

9 (5.7)

.63

 Triple

7 (1.3)

1 (0.6)

.80

Defibrillator

17 (3.2)

1 (0.6)

.14

Prior hospitalization for HF during past year

 0

301 (60)

123 (82)

<.0001

 1

136 (27)

17 (11)

.00011

  ≥ 2

67 (13)

10 (6.6)

.039

Followed by a cardiologist

367 (72)

92 (60)

.0090

Residence

  

.54

 At home

445 (83)

124 (79)

 

 Retirement institution

82 (15)

30 (19)

 

 Other institution

8 (1.5)

3 (1.9)

 

Self-sufficient

273 (52)

98 (64)

.012

Home assistance

 Housekeeper

157 (30)

27 (18)

.0036

 Family support

138 (26)

41 (27)

.99

 Nurse

129 (24)

21 (14)

.0060

 Known cognitive impairment

85 (16)

24 (15)

.88

 Bedridden

48 (8.99)

18 (12)

.45

  1. ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin II receptor blocker, HF heart failure, IQR interquartile range
  2. aData are presented as n (%) or median (IQR). All percentages are out of patients with non-missing data